CROTTI LIA

Neves, R., Crotti, L., Bains, S., Bos, J., Ye, D., Dagradi, F., et al. (2026). A Phenotype-Enhanced Variant Classification Framework to Decrease the Burden of Variants of Uncertain Significance in Type 2 Long QT Syndrome. JACC. CLINICAL ELECTROPHYSIOLOGY, 12(2), 350-359 [10.1016/j.jacep.2025.10.005]. Detail

De Michieli, L., Tini, G., Argiro, A., Milani, P., Zampieri, M., Caponetti, A., et al. (2026). Acute coronary syndrome and coronary artery disease in wild-type transthyretin amyloid cardiomyopathy: a DIAMOND sub-study. JOURNAL OF CARDIOVASCULAR MEDICINE, 27(2), 171-175 [10.2459/JCM.0000000000001844]. Detail

Schwartz, P., Crotti, L. (2026). Long QT Syndrome. Reply. THE NEW ENGLAND JOURNAL OF MEDICINE, 394(8), 826-827 [10.1056/NEJMc2518223]. Detail

De Backer, J., Haugaa, K., Hasselberg, N., De Hosson, M., Brida, M., Castelletti, S., et al. (2026). 2025 ESC guidelines for the management of cardiovascular disease and pregnancy, developed by the Task Force on the Management of Cardiovascular Disease and Pregnancy of the European Society of Cardiology (ESC) endorsed by the European Society of Gynecology (ESG). GIORNALE ITALIANO DI CARDIOLOGIA, 27(2), 1-113 [10.1714/4637.46475]. Detail

Bonacchi, G., Del Franco, A., Agostoni, P., Agricola, E., Ammirati, E., Baratta, P., et al. (2026). Baseline clinical profile of patients with obstructive hypertrophic cardiomyopathy in the Italian Mavacamten early access program. INTERNATIONAL JOURNAL OF CARDIOLOGY, 448(1 April 2026) [10.1016/j.ijcard.2025.134152]. Detail